Re: A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 191
(1)
◽
pp. 77-82
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 193
(3)
◽
pp. 857-862
◽
Keyword(s):